ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
7,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
9,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
10,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
12,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
13,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
14,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
15,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
16,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
17,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
19,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
20,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
21,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
22,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
23,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
24,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
26,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
26,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
27,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
27,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
